Article Information
History
- October 26, 2023.
Article Versions
- Version 1 (June 29, 2023 - 14:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sergey Senkin1,
- Sarah Moody2,
- Marcos Díaz-Gay3,4,5,
- Behnoush Abedi-Ardekani1,
- Thomas Cattiaux1,
- Aida Ferreiro-Iglesias1,
- Jingwei Wang2,
- Stephen Fitzgerald2,
- Mariya Kazachkova3,6,5,
- Raviteja Vangara3,4,5,
- Anh Phuong Le2,
- Erik N. Bergstrom3,4,5,
- Azhar Khandekar3,4,5,
- Burçak Otlu3,4,5,7,
- Saamin Cheema2,
- Calli Latimer2,
- Emily Thomas2,
- Joshua Ronald Atkins8,
- Karl Smith-Byrne8,
- Ricardo Cortez Cardoso Penha1,
- Christine Carreira9,
- Priscilia Chopard1,
- Valérie Gaborieau1,
- Pekka Keski-Rahkonen10,
- David Jones2,
- Jon W. Teague2,
- Sophie Ferlicot11,
- Mojgan Asgari12,
- Surasak Sangkhathat13,
- Worapat Attawettayanon14,
- Beata Świątkowska15,
- Sonata Jarmalaite16,17,
- Rasa Sabaliauskaite16,
- Tatsuhiro Shibata18,19,
- Akihiko Fukagawa19,20,
- Dana Mates21,
- Viorel Jinga22,
- Stefan Rascu22,
- Mirjana Mijuskovic23,
- Slavisa Savic24,
- Sasa Milosavljevic25,
- John M.S. Bartlett26,
- Monique Albert27,28,
- Larry Phouthavongsy28,
- Patricia Ashton-Prolla29,30,
- Mariana R. Botton31,
- Brasil Silva Neto32,33,
- Stephania Martins Bezerra34,
- Maria Paula Curado35,
- Stênio de Cássio Zequi36,37,38,39,
- Rui Manuel Reis40,41,
- Eliney Faria42,
- Nei Soares Menezes43,
- Renata Spagnoli Ferrari42,
- Rosamonde E. Banks44,
- Naveen S. Vasudev44,
- David Zaridze45,
- Anush Mukeriya45,
- Oxana Shangina45,
- Vsevolod Matveev46,
- Lenka Foretova47,
- Marie Navratilova47,
- Ivana Holcatova48,49,
- Anna Hornakova50,
- Vladimir Janout51,
- Mark Purdue52,
- Nathaniel Rothman52,
- Stephen J. Chanock52,
- Per Magne Ueland53,
- Mattias Johansson1,
- James McKay1,
- Ghislaine Scelo54,
- Estelle Chanudet55,
- Laura Humphreys2,
- Ana Carolina de Carvalho1,
- Sandra Perdomo1,
- Ludmil B. Alexandrov3,4,5,
- Michael R. Stratton2 and
- Paul Brennan1,*
- 1Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France,
- 2Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK,
- 3Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, USA,
- 4Department of Bioengineering, University of California San Diego, La Jolla, USA,
- 5Moores Cancer Center, University of California San Diego, La Jolla, USA,
- 6Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, USA,
- 7Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey,
- 8Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK,
- 9Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France,
- 10Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France,
- 11Service d’Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France,
- 12Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran,
- 13Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand,
- 14Department of Surgery, Urology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand,
- 15Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland,
- 16Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania,
- 17Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania,
- 18Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan,
- 19Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan,
- 20Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan,
- 21Occupational Health and Toxicology, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania,
- 22Urology Department, “Carol Davila” University of Medicine and Pharmacy - “Prof. Dr. Th. Burghele” Clinical Hospital, Bucharest, Romania,
- 23Clinic of Nefrology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia,
- 24Department of Urology, University Hospital “Dr D. Misovic” Clinical Center, Belgrade, Serbia,
- 25International Organization for Cancer Prevention and Research, Belgrade, Serbia,
- 26Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland,
- 27Centre for Biodiversity Genomics, University of Guelph, Guelph, Canada,
- 28Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Canada,
- 29Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil,
- 30Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil,
- 31Diagnostic Laboratory Service, Personalized Medicine, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil,
- 32Service of Urology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil,
- 33Post-Graduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil,
- 34Department of Anatomic Pathology, A.C. Camargo Cancer Center, São Paulo, Brazil,
- 35Department of Epidemiology, A.C. Camargo Cancer Center, São Paulo, Brazil,
- 36Department of Urology, A.C. Camargo Cancer Center, São Paulo, Brazil,
- 37National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, A.C. Camargo Cancer Center, São Paulo, Brazil,
- 38Latin American Renal Cancer Group – LARCG, São Paulo, Brazil,
- 39Department of Surgery, Division of Urology, Sao Paulo Federal University - UNIFESP, São Paulo, Brazil,
- 40Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil,
- 41Life and Health Sciences Research Institute (ICVS), School of Medicine, Minho University, Braga, Portugal,
- 42Department of Urology, Barretos Cancer Hospital, Brazil,
- 43Department of Pathology, Barretos Cancer Hospital, Brazil,
- 44Leeds Institute of Medical Research at St James’s, University of Leeds, Leeds, UK,
- 45Clinical Epidemiology, N.N.Blokhin National Medical Research Centre of Oncology, Moscow, Russia,
- 46Department of Urology, N.N.Blokhin National Medical Research Centre of Oncology, Moscow, Russia,
- 47Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic,
- 48Institute of Public Health & Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic,
- 49Department of Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic,
- 50Institute of Hygiene & Epidemiology, 1nd Faculty of Medicine, Charles University, Prague, Czech Republic,
- 51Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic,
- 52Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA,
- 53Bevital AS, Bergen, Norway,
- 54Observational & Pragmatic Research Institute Pte Ltd, Singapore, Singapore,
- 55Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands
- ↵*Corresponding author: Paul Brennan; email: brennanp{at}iarc.who.int
These authors contributed equally: Sergey Senkin, Sarah Moody